Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study

BACKGROUND: Direct-acting antiviral agents (DAAs) have shown high rates of sustained virological response in chronic hepatitis C virus (HCV) infection. However, the influence of DAAs on the course of kidney involvement in HCV-associated mixed cryoglobulinaemia (HCV-MC) has been little studied. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez de José, Ana, Carbayo, Javier, Pocurull, Anna, Bada-Bosch, Teresa, Cases Corona, Clara Maria, Shabaka, Amir, Ramos Terrada, Natàlia, Martinez Valenzuela, Laura, Huerta, Ana, Fernandez Lorente, Loreto, Malek-Marín, Tamara Gelen, Goicoechea, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886557/
https://www.ncbi.nlm.nih.gov/pubmed/33623683
http://dx.doi.org/10.1093/ckj/sfz178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886557/
https://www.ncbi.nlm.nih.gov/pubmed/33623683
http://dx.doi.org/10.1093/ckj/sfz178

Ejemplares similares